0001209191-23-014440.txt : 20230302 0001209191-23-014440.hdr.sgml : 20230302 20230302073642 ACCESSION NUMBER: 0001209191-23-014440 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230228 FILED AS OF DATE: 20230302 DATE AS OF CHANGE: 20230302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sabag Mark CENTRAL INDEX KEY: 0001721442 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16174 FILM NUMBER: 23696437 MAIL ADDRESS: STREET 1: 5 BASEL STREET, P.O. BOX 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 4951033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL INDUSTRIES LTD CENTRAL INDEX KEY: 0000818686 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 BAZEL ST STREET 2: P O B 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 49131 BUSINESS PHONE: 9729267267 MAIL ADDRESS: STREET 1: TEVA PHARMACEUTICAL INDUSTRIES LIMITED STREET 2: 5 BAZEL ST PO B 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 49131 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-28 0 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0001721442 Sabag Mark C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 124 DVORA HANEVI'A ST., TEL AVIV L3 6944020 ISRAEL 0 1 0 0 EVP, International Markets Ordinary Shares 2023-02-28 4 M 0 20598 A 198243 D Ordinary Shares 2023-02-28 4 M 0 50242 A 248485 D Restricted Share Units 2023-02-28 4 M 0 20598 0.00 D Ordinary Shares 20598 20599 D Restricted Share Units 2023-02-28 4 M 0 50242 0.00 D Ordinary Shares 50242 0 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. Restricted share units were granted on February 28, 2020 with 20,598 vested on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 20,599 vesting on February 28, 2024. Restricted share units were granted on February 7, 2023 pursuant to the satisfaction of performance criteria and vested on February 28, 2023. /s/ Dov Bergwerk as attorney-in-fact for Mark Sabag 2023-03-02